RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Chicago, IL · Flossmoor, IL · +110 more sites
5 recruiting migraine studies with a site in Naperville, IL.
Sponsor: Kallyope Inc.
Chicago, IL · Flossmoor, IL · +110 more sites
Sponsor: Pfizer
Chicago, IL · Naperville, IL · +167 more sites
Sponsor: Pfizer
Chicago, IL · Naperville, IL · +113 more sites
Sponsor: Kallyope Inc.
Chicago, IL · Flossmoor, IL · +110 more sites
Sponsor: AbbVie
Naperville, IL · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.